Processing
Research into applications using CRISPR-Cas systems for genome editing is expanding quickly. This presents a need for effective reagents and protocols for a wide variety of model systems beyond mammalian cultured cells.
Advantages of Alt-R CRISPR RNAs and proteins for genome editing
CRISPR guide RNAs. Use Alt-R CRISPR RNAs to direct potent, on-target genome editing. These length-optimized RNAs are chemically synthesized, which allows addition of modifications for increased nuclease resistance and reduced innate immune responses.
CRISPR proteins. Choose from several recombinant variants of Cas9 (Streptococcus pyogenes), as well as Cpf1 (Acidaminococcus sp. BV3L6) endonucleases. Alt-R S.p. Cas9 Nuclease 3NLS is suitable for most genome editing studies. Some experiments may benefit from use of Alt-R S.p. HiFi Cas9 Nuclease, a high-fidelity nuclease that has been engineered to reduce off-target effects while retaining the on-target potency of wild-type Cas9. Alt-R A.s. Cpf1 Nuclease 2NLS provides additional genome editing target sites, because it recognizes an AT-rich protospacer adjacent motif (PAM) rather than the CG-rich Cas9 PAM sequence.
If you are interested in knock-in experiments or other applications requiring homology-directed repair (HDR), consider using an Alt-R Cas9 nickase to create single-strand breaks. Use of a nickase variant with a pair of guide RNAs reduces off-target effects by requiring specific binding of 2 ribonucleoproteins (RNPs), and promotes homology-directed repair, in part, by creating overhanging DNA breaks. However, you will need 2 potent CRISPR target sites at an appropriate distance from your HDR target site.
Alt-R CRISPR RNPs. While the Alt-R CRISPR RNAs are compatible with CRISPR proteins from any source (e.g., cells that stably express CRISPR protein, or CRISPR proteins expressed from DNA or mRNA constructs), we recommend delivery of CRISPR reagents as RNPs by lipofection (e.g., Figure 1), electroporation, or microinjection. Cas9 RNPs are compatible with all 3 methods; however, for Cpf1 RNPs, we recommend electroporation and microinjection delivery methods.
Advantages of using Alt-R RNPs
- Efficient, on-target genome editing
- Precise control of editing complex delivery—cells will not contain templates that express unregulated levels of CRISPR RNAs or endonucleases
- Lower activation of cellular immune responses and, therefore, reduced toxicity—toxicity is often observed when using in vitro transcribed Cas9 mRNA or single guide RNAs (sgRNA)
Protocols and starting points are increasingly available
IDT scientists have developed detailed lipofection and electroporation protocols for using the Alt-R CRISPR-Cas9 System and the Alt-R CRISPR-Cpf1 System in mammalian cells (Table 1). With help from our collaborators, we also make user-submitted methods available for genome editing in other model systems. These protocols and methods are a good starting point for protocol optimization for your studies, and often offer tips for all aspects of genome editing experiments, from growth conditions through genome editing detection.
Table 1. Alt-R CRISPR System protocols and user methods.*
| Model system | Transfection method | IDT protocols |
| Cultured cells | Lipofection | [1] |
| Cultured cells | Electroporation | [2–6] |
| In vitro | — | [7] |
| Model system | Transfection method | User-submitted methods |
| Human pluripotent or embryonic stem cells | Electroporation | [8] |
| Mouse induced pluripotent stem cells | Electroporation | [9] |
| Mouse zygote | Electroporation | [10,11] |
| Mouse zygote | Microinjection | [12] |
| Zebrafish embryo | Microinjection | [13] |
| C. elegans | Injection | [14] |
* Visit www.idtdna.com/protocols to access the most up-to-date list of protocols and user-submitted methods. Visit the Alt-R CRISPR-Cas9 citations page to find peer-reviewed publications describing research using the Alt-R CRISPR-Cas9 system in yeast, primary human T cells, and more.
Do you have a protocol to share?
We are always interested in learning about successful editing in different model systems, and would like to serve as your resource for information about genome editing applications.
If you have a novel protocol for using Alt-R CRISPR RNA and/or nucleases that you would like to share with the research community, email us at CRISPR@idtdna.com to start the discussion.
